Skip to main content
. 2018 Aug 9;10(3):127. doi: 10.3390/pharmaceutics10030127

Table 1.

Comparison of the potent synthetic modulators in vitro.

Reference Compound Target Cytotoxicity (µM)
Ting-Chao Chou [49] N3 P-gp CCRF-CEM: 13 CCRF-CEM/VBL1000: 100
Bin [50] Compound 35 P-gp L292: >100 MDA435/LCC6: >100 MDA435/LCC6MDR: >100
Yang [45] Compound 23 P-gp L292: >100 MDA435/LCC6: >100 MDA435/LCC6MDR: >100
Wang [51] Compound 12 P-gp L292: >100 MDA435/LCC6: >100 MDA435/LCC6MDR: >100
Chen [53] 5 Bromo-tetrandrine P-gp KB: 5.14 KBv200: 6.17
Sun [54] W6 P-gp KB: ~2 KBv200: ~4 MCF-7: ~4.5 MCF-7/DOX: ~5
Zhu [55] Compound 26 P-gp HepG2/ADR: >150 MCF-7/ADR: >150
Kraege [29] GO-Y078 BCRP K562/BCRP: 0.31
Wong [56] Compound 51 MRP1, P-gp and BCRP L292: >100 LCC6: >100 LCC6MDR: >100
Wong [56] 4e MRP1 L292: >100 LCC6: >100 LCC6MDR: >100